tradingkey.logo

Bone Biologics Corp

BBLGW
View Detailed Chart
12.550USD
-6.240-33.21%
Close 02/06, 16:00ETQuotes delayed by 15 min
0.00Market Cap
--P/E TTM

Bone Biologics Corp

12.550
-6.240-33.21%
Intraday
1m
30m
1h
D
W
M
D

Today

-33.21%

5 Days

-20.32%

1 Month

+3.29%

6 Months

0.00%

Year to Date

-61.38%

1 Year

-86.13%

View Detailed Chart

TradingKey Stock Score

No stock score available due to insufficient data.

Bone Biologics Corp News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Bone Biologics Corp Info

Bone Biologics Corporation is a developer of orthobiologic products for spine fusion markets. It is focusing development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures, while additionally having rights to trauma and osteoporosis applications. It is a medical device company that is focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with demineralized bone matrix (DBM), is an osteopromotive recombinant protein that provides target specific control over bone regeneration. Its platform technology is its NELL-1, a proprietary skeletal specific growth factor which is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
Ticker SymbolBBLGW
CompanyBone Biologics Corp
CEOMr. Jeffrey Frelick
Websitehttps://www.bonebiologics.com/
KeyAI